206 related articles for article (PubMed ID: 32659407)
41. [Recent advances in molecular pathology of classic Hodgkin's lymphoma].
An G; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):133-6. PubMed ID: 20388387
[No Abstract] [Full Text] [Related]
42. Genomic distribution and possible functions of DNA hydroxymethylation in the brain.
Wen L; Tang F
Genomics; 2014 Nov; 104(5):341-6. PubMed ID: 25205307
[TBL] [Abstract][Full Text] [Related]
43. The role of 5-hydroxymethylcytosine in development, aging and age-related diseases.
López V; Fernández AF; Fraga MF
Ageing Res Rev; 2017 Aug; 37():28-38. PubMed ID: 28499883
[TBL] [Abstract][Full Text] [Related]
44. 5-Hydroxymethylcytosine in cord blood and associations of DNA methylation with sex in newborns.
Solomon O; Macisaac JL; Tindula G; Kobor MS; Eskenazi B; Holland N
Mutagenesis; 2019 Dec; 34(4):315-322. PubMed ID: 31587037
[TBL] [Abstract][Full Text] [Related]
45. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
46. Separating the wheat from the chaff in cHL.
Blachly JS
Blood; 2015 Feb; 125(7):1051-2. PubMed ID: 25678431
[No Abstract] [Full Text] [Related]
47. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
Carella A; Tejedor JR; García MG; Urdinguio RG; Bayón GF; Sierra M; López V; García-Toraño E; Santamarina-Ojeda P; Pérez RF; Bigot T; Mangas C; Corte-Torres MD; Sáenz-de-Santa-María I; Mollejo M; Meléndez B; Astudillo A; Chiara MD; Fernández AF; Fraga MF
Int J Cancer; 2020 Jan; 146(2):373-387. PubMed ID: 31211412
[TBL] [Abstract][Full Text] [Related]
48. Quantitation and mapping of the epigenetic marker 5-hydroxymethylcytosine.
Qing Y; Tian Z; Bi Y; Wang Y; Long J; Song CX; Diao J
Bioessays; 2017 May; 39(5):. PubMed ID: 28332209
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
[TBL] [Abstract][Full Text] [Related]
50. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
[TBL] [Abstract][Full Text] [Related]
52. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
53. Rapid separation of mononuclear hodgkin from multinuclear reed-sternberg cells.
Kongruttanachok N; Cayre YE; Knecht H; Mai S
Lab Hematol; 2014 Mar; 20(1):2-6. PubMed ID: 24694783
[TBL] [Abstract][Full Text] [Related]
54. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
55. Reed-Sternberg-Like Cells in Non-Hodgkin Lymphomas.
Gomez-Gelvez JC; Smith LB
Arch Pathol Lab Med; 2015 Oct; 139(10):1205-10. PubMed ID: 26414463
[TBL] [Abstract][Full Text] [Related]
56. Reed-Sternberg cells form by abscission failure in the presence of functional Aurora B kinase.
Xavier de Carvalho A; Maiato H; Maia AF; Ribeiro SA; Pontes P; Bickmore W; Earnshaw WC; Sambade C
PLoS One; 2015; 10(5):e0124629. PubMed ID: 25933052
[TBL] [Abstract][Full Text] [Related]
57. Classical Hodgkin Lymphoma With Aberrant CD8 Expression: A Clinicopathologic Study of Five Cases.
Mirzamani N; Zhang X; Brody J; Spitzer SG; Sen F; Hsu P
Int J Surg Pathol; 2019 Apr; 27(2):166-173. PubMed ID: 30058423
[TBL] [Abstract][Full Text] [Related]
58. c-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma.
Leventaki V; Drakos E; Karanikou M; Psatha K; Lin P; Schlette E; Eliopoulos A; Vassilakopoulos TP; Papadaki H; Patsouris E; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2014 Mar; 45(3):565-72. PubMed ID: 24457077
[TBL] [Abstract][Full Text] [Related]
59. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.
Vogel MJ; Xie L; Guan H; Tooze RM; Maier T; Kostezka U; Maier HJ; Holzmann K; Chan FC; Steidl C; Reichel JB; Weitzer CD; Gehringer F; Kick AB; Cesarman E; Roshal M; Gascoyne RD; Möller P; Wirth T; Ushmorov A
Blood; 2014 Nov; 124(20):3118-29. PubMed ID: 25232062
[TBL] [Abstract][Full Text] [Related]
60. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.
Hsi ED
Leuk Lymphoma; 2008 Sep; 49(9):1668-80. PubMed ID: 18798102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
